← Back to headlines
F.D.A. Faces Upset Over Denials of New Drugs
Agency officials promise fast reviews of new treatments while vowing they will not be a “rubber stamp” for the industry. But patients with rare diseases view recent decisions as signs that the doors are closing on their options.
5 Mar, 10:01 — 5 Mar, 10:01
ℹOnly 1 source covers this story
Related Stories
Which coffee do you drink every morning – instant, homemade, or filter? One protects the heart, and another dangerously increases cholesterol
4m ago
Scientists reprogram anti-tumor cells
6m ago
Recommendations of the Hellenic Cardiological Society for vaccination in cardiovascular patients
11m ago
Birth rooms instead of maternity wards? Hospitals do not want the new solution
12m ago